Accuray (ARAY) Total Non-Current Liabilities (2011 - 2026)
Accuray (ARAY) posted quarterly Total Non-Current Liabilities of $399.0 million for Q1 2026, up 29807.8% year-over-year from N/an in Q1 2025, and up 36071.35% quarter-over-quarter from $1.1 million in Q4 2025.
Accuray (ARAY) Total Non-Current Liabilities (2011 - 2026) Analysis & Trends
Accuray's Total Non-Current Liabilities history runs 16 years deep, the most recent figure standing at $399.0 million for Q1 2026.
- In Q1 2026, Total Non-Current Liabilities rose 29807.8% year-over-year to $399.0 million; the TTM figure through Mar 2026 stood at $399.0 million (up 29807.8% YoY), while the FY2025 annual figure was $1.3 million, up 1408.14% from the prior year.
- Total Non-Current Liabilities for Q1 2026 stood at $399.0 million, up from $1.1 million in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $399.0 million in Q1 2026, with the low at $86000.0 in Q2 2024.
- The 5-year median for Total Non-Current Liabilities is $862000.0 (2022), against an average of $24.2 million.
- The sharpest annual moves came in 2023 and 2026: Total Non-Current Liabilities plunged 75.5% in 2023, then soared 29807.8% in 2026.
- Accuray's Total Non-Current Liabilities stood at $547000.0 in 2022, then slumped by 75.5% to $134000.0 in 2023, then soared by 951.49% to $1.4 million in 2024, then fell by 21.72% to $1.1 million in 2025, then jumped by 36071.35% to $399.0 million in 2026.
- Business Quant data shows ARAY's Total Non-Current Liabilities at $399.0 million in Q1 2026, $1.1 million in Q4 2025, and $1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | - |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Accuray | 37.80 Mn | -1.90 Mn | 25.29 Mn | 398.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 398.97 Mn |
| Dec 31, 2025 | 1.10 Mn |
| Sep 30, 2025 | 1.13 Mn |
| Jun 30, 2025 | 1.30 Mn |
| Mar 31, 2025 | 1.33 Mn |
| Dec 31, 2024 | 1.41 Mn |
| Sep 30, 2024 | 1.50 Mn |
| Jun 30, 2024 | 86,000.00 |
| Mar 31, 2024 | 113,000.00 |
| Dec 31, 2023 | 134,000.00 |
| Sep 30, 2023 | 174,000.00 |
| Jun 30, 2023 | 227,000.00 |
| Mar 31, 2023 | 398,000.00 |
| Dec 31, 2022 | 547,000.00 |
| Sep 30, 2022 | 669,000.00 |
| Jun 30, 2022 | 862,000.00 |
| Mar 31, 2022 | 1.06 Mn |
| Dec 31, 2021 | 1.00 Mn |
| Sep 30, 2021 | 1.15 Mn |
| Jun 30, 2021 | 1.30 Mn |